ID
41567
Beschrijving
Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. This form (Pharmacogenetic Research Consent, Saliva Sample Collection) is to be filled out during the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00784550
Trefwoorden
Versies (1)
- 11-11-20 11-11-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
11 november 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550
Pharmacogenetic Research Consent, Saliva Sample Collection
- StudyEvent: ODM
Beschrijving
Pharmacogenetic research consent
Beschrijving
Informed consent for pharmacogenetic research
Datatype
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
Beschrijving
Date informed consent for pharmacogenetics obtained
Datatype
date
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C0011008
Beschrijving
Saliva collection for pharmacogenetic research
Datatype
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0455046
Beschrijving
Date Saliva Sample for pharmacogenetic research was collected
Datatype
date
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0455046
- UMLS CUI [1,3]
- C0011008
Beschrijving
Reason for not obtaining informed consent for pharmacogenetic research
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C2347500
- UMLS CUI [1,4]
- C1882120
Beschrijving
Other reason for not obtaining informed consent for pharmacogenetic research
Datatype
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C1882120
- UMLS CUI [1,4]
- C0205394
- UMLS CUI [1,5]
- C0566251
Beschrijving
[hidden] This item will be calculated by InForm
Datatype
text
Alias
- UMLS CUI [1]
- C2347029
Similar models
Pharmacogenetic Research Consent, Saliva Sample Collection
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0455046 (UMLS CUI [1,2])
C0455046 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,3])
C1882120 (UMLS CUI [1,4])
C2347500 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C0566251 (UMLS CUI [1,5])